Advertisement

Search Results for "High Dose Busulfan Fludarabine Atg"

00:21 EDT 20th May 2013 | BioPortfolio

Original Source: Busulfan, Fludarabine, Antithymocyte Globulin (ATG) & Cyclophosphamide Conditioning Bone Marrow Transplant (BMT) for Patients With Sickle Cell Disease (SCD)

Some of the drugs used in the conditioning treatment injure blood vessels. This damage may be responsible for transplant-related neurological problems seen in patients with sickle cell disease. The reason that patients with sickle cell disease are more prone to the effects of the conditioning treatment drugs may be that many of them have pre-existing damage to the blood vessels that supply their brains. The primary goal of this study is to develop a conditioning treatment that...

Matching Channels

Prostate Cancer

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...

Thimerosal Preservative

Thimerosal is a mercury-based preservative that has been used for decades in the United States in multi-dose vials (vials containing more than one dose) of some vaccines to prevent the growth of ger...

High administrative costs

High anion gap acidosis

Vitamin E Toxicity

Research has not found any adverse effects from consuming vitamin E in food. However, high doses of alpha-tocopherol supplements can cause hemorrhage and interrupt blood coagulation in animals, and...

Matching News

Fludarabine can't replace cyclophosphamide with busulfan myeloablative conditioning

NEW YORK (Reuters Health) - In patients with leukemia and myelodysplastic syndrome who need myeloablative conditioning before allogeneic hematopoietic cell transplantation (HCT), the less toxic...

In Waldenstrm macroglobulinemia, fludarabine yields better survival than chlorambucil

NEW YORK (Reuters Health) - Fludarabine improves survival compared with chlorambucil in patients with Waldenstrm macroglobulinemia (WM) and related disorders, according to the multicenter WM1 stud...

Long-term survival after allogeneic-matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year-old boy with ataxia-telangiectasia syndrome and ALL

Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia

Standard-Dose vs High-Dose Multivitamin Supplements for HIV

To the Editor: In the study by Dr Isanaka and colleagues, patients with human immunodeficiency virus (HIV) receiving highly active antiretroviral therapy were treated either with standard-dose or high...

Human medicines European Public Assessment Report (EPAR): Busilvex, busulfan, Revision: 9, Authorised

Busulfan Conditioning Enhances Engraftment of Hematopoietic Donor-derived Cells in the Brain Compared With Irradiation

Human medicines European Public Assessment Report (EPAR): Busilvex, busulfan, Revision: 10, Authorised

Matching PubMed Articles

Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients.

Personalizing intravenous (IV) busulfan doses in children using therapeutic drug monitoring (TDM) is an integral component of hematopoietic cell transplant. The authors sought to characterize initial...

ORAL LORAZEPAM PREVENTS SEIZURE DURING HIGH-DOSE BUSULFAN IN CHILDREN UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: A Prospective Study.

High-dose Busulfan in combination chemotherapy has been used commonly for hematopoietic stem cell transplantation. It crosses the blood-brain barrier and could cause seizure. Benzodiazepines have been...

Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine/i.v. busulfan (FluBu4).

The assessment of a hematopoietic stem cell transplant (HSCT)-specific comorbidity index (HCT-CI) has been developed to predict the risk of TRM in patients undergoing allogeneic HSCT. As the myeloabla...

Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study.

BACKGROUND AND PURPOSE: Fludarabine is an adenine nucleoside analogue that has significant activity in hematological malignancies and has shown promising activity in combination with radiation in prec...

Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia.

We conducted a phase I trial to determine the maximum tolerated dose (MTD) of clofarabine with high-dose busulfan followed by allogeneic stem cell transplantation (SCT) in patients with high-risk and...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement